Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study

Agnieszka Zienciuk-Krajka1, Maciej Sterliński, Artur Filipecki

  • 1Dept. of Cardiology and Electrotherapy, Medical University of Gdańsk, Gdańsk, Poland. agzien@gumed.edu.pl.

Kardiologia Polska
|September 26, 2018
PubMed

Insights

Implantable cardioverter-defibrillator (ICD) therapy is effective for long QT syndrome (LQTS) patients, but complications are frequent. Careful programming may reduce some adverse events, but others persist.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Genetics

Background:

  • Implantable cardioverter-defibrillator (ICD) therapy is established for preventing sudden cardiac death.
  • Limited data exist on ICD outcomes in young, healthy long QT syndrome (LQTS) patients.

Purpose of the Study:

  • To evaluate ICD therapy outcomes in LQTS patients.
  • To identify risk factors for appropriate and inappropriate ICD discharges.
  • To assess ICD-related complications in this population.

Main Methods:

  • Retrospective analysis of 67 LQTS patients from 14 centers.
  • Data collection included demographics, clinical status, and ICD therapy details.
  • Median follow-up was 48 months.

Main Results:

  • 58% of patients received ICD therapy during follow-up.
  • Risk factors for appropriate therapy included syncope, prior pacemaker use, single-chamber ICD, and noncompliance.
  • 57% of patients experienced at least one complication; no predictors for inappropriate shocks were found.

Conclusions:

  • ICD therapy is effective in nearly half of LQTS patients.
  • High rates of early and late complications necessitate careful patient selection and management.
  • Modern programming may reduce some adverse events, but not all.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
280
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
159
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
652
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.0K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.0K
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
563